| Literature DB >> 33584291 |
Zeeshan Javed1, Khushbukhat Khan2, Amna Rasheed3, Haleema Sadia4, Shahid Raza1, Bahare Salehi5, William C Cho6, Javad Sharifi-Rad7,8, Wojciech Koch9, Wirginia Kukula-Koch10, Anna Głowniak-Lipa11, Paweł Helon12.
Abstract
Prostate cancer (PCa) is with rising incidence in male population globally. It is a complex anomaly orchestrated by a plethora of cellular processes. Transforming growth factor-beta (TGF-β) signaling is one of the key signaling pathways involved in the tumorigenesis of PCa. TGF-β signaling has a dual role in the PCa, making it difficult to find a suitable therapeutic option. MicroRNAs (miRNAs) mediated regulation of TGF-β signaling is responsible for the TGF-ß paradox. These are small molecules that modulate the expression of target genes and regulate cancer progression. Thus, miRNAs interaction with different signaling cascades is of great attention for devising new diagnostic and therapeutic options for PCa. Natural compounds have been extensively studied due to their high efficacy and low cytotoxicity. Here, we discuss the involvement of TGF-ß signaling in PCa with the interplay between miRNAs and TGF-β signaling and also review the role of natural compounds for the development of new therapeutics for PCa.Entities:
Keywords: biomarkers; miRNAs; natural compounds; prostate cancer; therapeutics; transforming growth factor-beta signaling
Year: 2021 PMID: 33584291 PMCID: PMC7873640 DOI: 10.3389/fphar.2020.613464
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810